Abiopharma

New Form 4 - DANAHER CORP /DE/ Filed: 2025-07-28 AccNo: 0000313616-25-000170 Size: 6 KB

New Form 4 - DANAHER CORP /DE/ Filed: 2025-07-28 AccNo: 0000313616-25-000168 Size: 6 KB

New Form 4 - DANAHER CORP /DE/ Filed: 2025-07-28 AccNo: 0000313616-25-000167 Size: 6 KB

New Form 8-K - Salarius Pharmaceuticals, Inc. Filed: 2025-07-28 AccNo: 0001615219-25-000076 Size: 142 KB Item 8.01: Other Events

New Form 4 - DANAHER CORP /DE/ Filed: 2025-07-28 AccNo: 0000313616-25-000165 Size: 6 KB

New Form 8-K - PTC THERAPEUTICS, INC. Filed: 2025-07-28 AccNo: 0001558370-25-009663 Size: 208 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 4 - DANAHER CORP /DE/ Filed: 2025-07-28 AccNo: 0000313616-25-000164 Size: 6 KB

New Form 4 - IQVIA HOLDINGS INC. Filed: 2025-07-28 AccNo: 0001478242-25-000118 Size: 5 KB

New Form 4 - IQVIA HOLDINGS INC. Filed: 2025-07-28 AccNo: 0001478242-25-000117 Size: 5 KB

New Form 4 - DANAHER CORP /DE/ Filed: 2025-07-28 AccNo: 0000313616-25-000163 Size: 6 KB

New Form 4 - IQVIA HOLDINGS INC. Filed: 2025-07-28 AccNo: 0001478242-25-000116 Size: 5 KB

Notification from BriaCell Therapeutics Corp.

New Form 10-K/A - Autonomix Medical, Inc. Filed: 2025-07-28 AccNo: 0001437749-25-023669 Size: 679 KB

New Form 4 - IQVIA HOLDINGS INC. Filed: 2025-07-28 AccNo: 0001478242-25-000115 Size: 5 KB

New Form SCHEDULE 13G - Vireo Growth Inc. Filed: 2025-07-28 AccNo: 0001104659-25-071205 Size: 7 KB